Early Detection of Developmental Abnormalities of Preterm Infants at 5 Years of Age
Early Detection and Prevention of Health Complications in Premature Infants - Early Detection of Developmental Abnormalities of Preterm Infants at 5 Years of Age
Early Detection and Prevention of Health Complications in Premature Infants - Early Detection of Developmental Abnormalities of Preterm Infants at 5 Years of Age
Sponsor study identifier
interventional
210
1 country
4
Study Start
September 23, 2025
Actual (reported)Primary Completion
November 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
February 28, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The project is a national, prospective, multicenter, interventional pilot project focused on the follow up of 5 year old children that were born prematurely. The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of children born prematurely. This will minimize the negative impacts on the overall development of the child and the family of the prematurely born children.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 28, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 23, 2025
Actual (reported)January 26, 2026
Actual (reported)February 6, 2026
Actual (reported)November 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
February 28, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Proportion of premature infants with identified pathology at 5 years (overall, by detected pathology)
During study participation (up to 3 days)
Proportion of premature infants referred to a specialized center (overall, by detected pathology)
During study participation (up to 3 days)
Eligible children are invited to undergo a comprehensive pediatric evaluation, including vision screening (Plusoptix) and speech and language tests (TEPO - sentence comprehension, TEPRO - vocabulary production). Subsequently, children are referred for psychological (IDS-P), motor (MABC-2), and pulmonary (spirometry) assessments. If any deviations are identified, the child is referred to appropriate specialists (e.g., rehabilitation physician, speech therapist, psychiatrist, ophthalmologist).
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
České Budějovice Hospital
České Budějovice, Czech Republic, Czechia
Hospital Havlíčkův Brod
Havlíčkův Brod, Czech Republic, Czechia
County Hospital Liberec
Liberec, Czech Republic, Czechia
Daniela Marková, M.D.
General Hospital University in Prague
Richard Plavka, prof.
General Hospital University in Prague
First Submitted
January 26, 2026
First Posted
February 6, 2026
Study Start
September 23, 2025
Actual (reported)Primary Completion
November 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Contact the study team to confirm eligibility.
General University Hospital
Prague, Czech Republic, Czechia
Study Completion
February 28, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
February 6, 2026
Record last verified: 2026-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: